Trial Site Detail
Drug: |
Regorafenib (SDH) |
|||
|---|---|---|---|---|
Trial: |
Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST (REGISTRI) |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
|||
Centre Léon Bérard28 rue Laennec |
Principal Investigator: |
Jean Yves-Blay, MD, PhD |
|---|---|
Contact: |
Julien Gautier julien.gautier@lyon.unicancer.fr |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
Centre Léon Bérard Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.